Your search returned 160 results.

Results
	1.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas PMID: 28104741 Year: 2017 Citation: Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D DOI: https://dx.doi.org/10.2967/jnumed.116.179366 Add to cart (remove)
	2.	Radioiodine Theranostics: Increasing Dialogue and Collaboration. MedStar authors: Van Nostrand, Douglas PMID: 28970353 Year: 2017 Citation: Journal of Nuclear Medicine. 58(10):19N-20N, 2017 Oct Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D Add to cart (remove)
	3.	Advanced differentiated thyroid cancer: when to stop radioiodine?. MedStar authors: Van Nostrand, Douglas PMID: 31271271 Year: 2019 Citation: The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Giovanella L, van Nostrand D DOI: https://dx.doi.org/10.23736/S1824-4785.19.03191-1 Add to cart (remove)
	4.	18F sodium fluoride PET imaging MedStar authors: Garcia, CarlosA Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Garcia CA Local accession number: 2015_1 Add to cart (remove)
	5.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	6.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	7.	Characterization of salivary gland side effects secondary to 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors: Garcia, Carlos Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Garcia C Local accession number: 2013_2 Add to cart (remove)
	8.	Evaluation of lymphoid organs by FDG PET/CT in high risk sarcoma patients receiving immunotherapy (IT) with tumor vaccine compared with tumor vaccine and IL-7. MedStar authors: Khorjekar, Gauri Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Millo C, Khorjekar G, Merchant M, Sioka C, Mackall C Local accession number: 2013_16 Add to cart (remove)
	9.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_4 Add to cart (remove)
	10.	Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L Local accession number: 2013_7 Add to cart (remove)
	11.	Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Hall J, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_7 Add to cart (remove)
	12.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_233 Add to cart (remove)
	13.	The Utility of "Blind" 131I treatments for differentiated thyroid cancer: an educational exhibit. MedStar authors: Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D Local accession number: 2013_234 Add to cart (remove)
	14.	Frequency, duration and severity of salivary side effects in DTC patients with onset at 3 to 12 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors: Gomes Lima, Christiane J Mete, Mihriye Mete, Mihriye Van Nostrand, Douglas Wu, Di Year: 20172016 Citation: Unpublished 2017/04/01 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bloom G Brennan MT Gomes Lima CJ Hall JP Khorjekar G McIver B Mete M Van Nostrand D Wu D Local accession number: A2017_314 Add to cart (remove)
	15.	Rapid wash out: comparison of Primary (pHPTH) versus Secondary Hpth (sHPTH) and utility of dual radiopharmaceutical acquisition with 99mtc-sestamibi and 123I for tumor localization. MedStar authors: Kulkarni, Kanchan P Sharma, Shiksha Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Kulkarni K Sharma S Local accession number: A2017_042 Add to cart (remove)
	16.	Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications. MedStar authors: Van Nostrand, Douglas PMID: 30105931 Year: 2018 Citation: Thyroid. 28(9):1083-1093, 2018 Sep. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D DOI: https://dx.doi.org/10.1089/thy.2018.0048 Add to cart (remove)
	17.	Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer. MedStar authors: Brown, Taneshea A Van Nostrand, Douglas Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Brown TA Byard J Hobbs R Plyku D Sgouros G Van Nostrand D. Wu D Local accession number: B2018454 Add to cart (remove)
	18.	Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_7 Add to cart (remove)
	19.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	20.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	21.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_235 Add to cart (remove)
	22.	Detection of 131I in public places: a national survey. MedStar authors: Orquiza, Michael H Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Van Nostrand D,Orquiza M, Bloom G Local accession number: 2014.1_131 Add to cart (remove)
	23.	I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response. MedStar authors: Garcia, Carlos Plyku, Donika Van Nostrand, Douglas Wu, Di PMID: 35119623 Year: 2022 Citation: Annals of Nuclear Medicine. 36(3):213-223, 2022 Mar. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Garcia C, Hobbs RF, Plyku D, Sgouros G, Van Nostrand D, Wu D DOI: https://dx.doi.org/10.1007/s12149-021-01655-y Add to cart (remove)
	24.	The BEIR VII Estimates of Low-Dose Radiation Health Risks Are Based on Faulty Assumptions and Data Analyses: A Call for Reassessment. MedStar authors: Van Nostrand, Douglas PMID: 29475999 Year: 2018 Citation: Journal of Nuclear Medicine. 59(7):1017-1019, 2018 07. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Greenspan BS, Maurer AH, Phillips WT, Sacks B, Siegel JA, Silberstein EB, Taylor AT, Van Nostrand D DOI: https://dx.doi.org/10.2967/jnumed.117.206219 Add to cart (remove)
	25.	Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer. [Review] MedStar authors: Van Nostrand, Douglas PMID: 28760238 Year: 2017 Citation: Endocrinology & Metabolism Clinics of North America. 46(3):783-793, 2017 Sep Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Van Nostrand D DOI: https://dx.doi.org/10.1016/j.ecl.2017.04.007 Add to cart (remove)
	26.	Radioiodine refractory differentiated thyroid cancer. [Review] MedStar authors: Van Nostrand, Douglas PMID: 29650270 Year: 2018 Citation: Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Chen L, Cheng L, Jin Y, Liu M, Van Nostrand D DOI: https://dx.doi.org/10.1016/j.critrevonc.2018.03.012 Add to cart (remove)
	27.	Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer. MedStar authors: Van Nostrand, Douglas PMID: 31160436 Year: 2019 Citation: Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D Add to cart (remove)
	28.	Overview of the Martinique Meetings: What Has Been Established and Where Are We Going?. MedStar authors: Van Nostrand, Douglas PMID: 31160431 Year: 2019 Citation: Journal of Nuclear Medicine. 60(6):15N, 2019 Jun. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Ahuja S, Avram AM, Greenspan BS, Gulec S, Van Nostrand D Add to cart (remove)
	29.	Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images Are Performed Equally. MedStar authors: Van Nostrand, Douglas PMID: 31184275 Year: 2019 Citation: Thyroid. 29(7):901-909, 2019 Jul. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D DOI: https://dx.doi.org/10.1089/thy.2018.0690 Add to cart (remove)
	30.	The Martinique Principles. MedStar authors: Van Nostrand, Douglas PMID: 31227575 Year: 2019 Citation: Journal of Nuclear Medicine. 60(9):1334-1335, 2019 09. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Letter Form of publication: Journal Article All authors: Ahuja S, Avram AM, Dillehay G, Greenspan BS, Gulec S, Van Nostrand D DOI: https://dx.doi.org/10.2967/jnumed.119.232066 Add to cart (remove)
	31.	I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study. MedStar authors: Atkins, Frank Brown, Taneshea A Moreau, Shari Van Nostrand, Douglas Wu, Di Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Atkins F Brown T Frey E Lodge M Moreau S Plyku D Van Nostrand D Wu D Local accession number: A2017_428 Add to cart (remove)
	32.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D Local accession number: 2013_2 Add to cart (remove)
	33.	Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_16 Add to cart (remove)
	34.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Duong E, Khorjekar G, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	35.	Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_2 Add to cart (remove)
	36.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	37.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	38.	18F sodium fluoride PET imaging MedStar authors: Garcia, CarlosA Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Garcia CA Local accession number: 2015_1 Add to cart (remove)
	39.	Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer. MedStar authors: Van Nostrand, Douglas Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Hobbs R Brown T Byard J Plyku D Sgouros G Van Nostrand D. Wu D Local accession number: B201872 Add to cart (remove)
	40.	Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and <sup>123</sup>I for localization of rapid washout parathyroid adenomas. MedStar authors: Kulkarni, Kanchan Van Nostrand, Douglas PMID: 30706095 Year: 2019 Citation: Osteoporosis International. 30(5):1051-1057, 2019 May. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Kulkarni K, Kushchayev SV, Kushchayeva YS, Tella SH, Van Nostrand D DOI: https://dx.doi.org/10.1007/s00198-019-04846-6 Add to cart (remove)
	41.	Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology. MedStar authors: Van Nostrand, Douglas PMID: 32812307 Year: 2020 Citation: Head & Neck. 2020 Aug 19 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Angelos P, Bernet V, Boucai L, Buchholzer S, Burkey B, Eisele D, Erkul E, Faure F, Freitag SK, Gillespie MB, Harrell RM, Hartl D, Haymart M, Leffert J, Mandel S, Marchal F, Miller BS, Morris J, Pearce EN, Rahmati R, Randolph G, Ryan WR, Schaitkin B, Schlumberger M, Singer MC, Stack BC, Van Nostrand D, Wong KK DOI: https://dx.doi.org/10.1002/hed.26417 Add to cart (remove)
	42.	The utility of "blind" 131I treatments for differentiated thyroid cancer (DTC): an educational exhibit MedStar authors: Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Elboga U, Zeki C, Aktolun C, Van Nostrand D Local accession number: 2013_8 Add to cart (remove)
	43.	GU and thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2014.1_1 Add to cart (remove)
	44.	I-131 remnant ablation and adjuvant treatment: an interactive program MedStar authors: Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2014.1_1 Add to cart (remove)
	45.	Does a negative 124I pre-therapy scan in patients with elevated thyroglobulin predict a negative131I post-therapy scan? Updated results. MedStar authors: Khorjekar, Gauri Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Van Nostrand D, Moreau S, Burman K, Chennupati S, Bandaru V, Wartofsky L Local accession number: 2013_2 Add to cart (remove)
	46.	18F sodium fluoride PET imaging MedStar authors: Garcia, CarlosA Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Garcia CA Local accession number: 2015_1 Add to cart (remove)
	47.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	48.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	49.	Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_236 Add to cart (remove)
	50.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based 3D radiobiological dosimetry (3D-RD) for 131I therapy of metastatic differentiated thyroid cancer (DTC) - organ dosimetry MedStar authors: Atkins, Francis Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Plyku D, Hobbs FR, Srinivasan S, Atkins F, Van Nostrand D, Sgouros G Local accession number: 2015_188 Add to cart (remove)
	51.	I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study. MedStar authors: Atkins, Frank Brown, Taneshea A Moreau, Shari Van Nostrand, Douglas Wu, Di Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Atkins FB Brown TA Frey EC Lodge MA Moreau SL Plyku D Van Nostrand D Wu D Local accession number: A2017_004 Add to cart (remove)
	52.	Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. MedStar authors: Van Nostrand, Douglas PMID: 30900516 Year: 2019 Citation: Thyroid. 29(4):461-470, 2019 04. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Fuhrer D, Giovanella L, Greenspan B, Hegedus L, Luster M, Muylle K, Smit JWA, Tuttle RM, Van Nostrand D, Verburg FA DOI: https://dx.doi.org/10.1089/thy.2018.0597 Add to cart (remove)
	53.	Number of Foci of Functioning Thyroid Tissue Remaining after Thyroidectomy for Differentiated Thyroid Cancer: Institutional Experience. MedStar authors: Khorjekar, Gauri Kulkarni, Kanchan Mete, Mihriye Van Nostrand, Douglas PMID: 28553178 Year: 2017 Citation: World Journal of Nuclear Medicine. 16(2):122-125, 2017 Apr-Jun Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Khorjekar G, Kulkarni K, Mete M, Van Nostrand D DOI: https://dx.doi.org/10.4103/1450-1147.203066 Add to cart (remove)
	54.	Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade. MedStar authors: Van Nostrand, Douglas PMID: 31616967 Year: 2019 Citation: European Journal of Nuclear Medicine & Molecular Imaging. 2019 Oct 15 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Flux G, Giovanella L, Luster M, Muylle K, van Nostrand D, Verburg FA DOI: https://dx.doi.org/10.1007/s00259-019-04479-1 Add to cart (remove)
	55.	Brief progress report from the intersocietal working group on differentiated thyroid cancer. MedStar authors: Van Nostrand, Douglas PMID: 32166513 Year: 2020 Citation: European Journal of Nuclear Medicine & Molecular Imaging. 2020 Mar 12 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Editorial Form of publication: Journal Article All authors: Ahuja S, Avram AM, Bardies M, Bernet V, Bourguet P, Daniels GH, Draganescu C, Fuhrer-Sakel D, Greenspan B, Gulec S, Hegedus L, Jonklaas J, Luster M, Oyen W, Smit J, Tuttle RM, Van Nostrand D, Verburg FA, Zerdoud S DOI: https://dx.doi.org/10.1007/s00259-020-04744-8 Add to cart (remove)
	56.	David C. Moses, MD (1940-2020). MedStar authors: Van Nostrand, Douglas PMID: 32499287 Year: 2020 Citation: Journal of Nuclear Medicine. 61(6):20N, 2020 Jun. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D Add to cart (remove)
	57.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	58.	124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Atkins F, Khorjekar G, Orquiza MD Local accession number: 2013_2 Add to cart (remove)
	59.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G Local accession number: 2013_7 Add to cart (remove)
	60.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer with suspected bone metastases. MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_2 Add to cart (remove)
	61.	Current use and controversies for I-131 in thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2014.1_1 Add to cart (remove)
	62.	18F sodium fluoride PET imaging MedStar authors: Garcia, CarlosA Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Garcia CA Local accession number: 2015_1 Add to cart (remove)
	63.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	64.	Evaluation of the relationship of reproductive hormones to radioiodine breast uptake in patients with differentiated thyroid cancer: a pilot study. MedStar authors: Kulkarni, Kanchan P Kumar, Anagha Van Nostrand, Douglas Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Kulkarni K Kumar A Van Nostrand D. Wu D Local accession number: B201870 Add to cart (remove)
	65.	The use of diuretics for increasing radioiodine (RAI) uptake in patients with well-differentiated thyroid cancer MedStar authors: Orquiza, Michael H Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Van Nostrand D Local accession number: 2014.1_135 Add to cart (remove)
	66.	Frequency, duration and severity of salivary effects in DTC patients with onset at 7 weeks to 3 months after I-131 therapy: an analysis of the Thyca National Survey. MedStar authors: Gomes Lima, Christiane J Mete, Mihriye Mete, Mihriye Van Nostrand, Douglas Wu, Di Year: 20172016 Citation: Unpublished 2017/04/01 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bloom G Brennan MT Gomes Lima CJ Hall JP Khorjekar G McIver B Mete M Van Nostrand D Wu D Local accession number: A2017_313 Add to cart (remove)
	67.	A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors: Brennan, Michael T Hall, Jordan Khorjekar, Gauri Van Nostrand, Douglas Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bloom G Brennan MT Hall J Khorjekar G McIver B Van Nostrand D Wu D Zeymo A Local accession number: A2017_050 Add to cart (remove)
	68.	Sex-specific expression of the histone lysine-specific demethylases in normal thyroid and thyroid cancer. MedStar authors: Burman, Kenneth D Costello, John Shobab, Leila Wartofsky, Leonard Year: 2018 Institution: MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman KD Costello J Jensen K Mendonca-Torres MF Patel A Shobab L Vasko V. Wartofsky L Local accession number: B2018639 Add to cart (remove)
	69.	Nationwide survey on the changes in release of I-131 therapy patients after the implementation of the 2011 NRC regulatory policy. MedStar authors: Burman, Kenneth D Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Bloom G Burman KD Van Nostrand D. Wartofsky L Wu D Local accession number: B2018640 Add to cart (remove)
	70.	The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: systematic review and meta-analysis. MedStar authors: Burman, Kenneth D Heimlich, Layla Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Heimlich L Van Nostrand D. Wartofsky L Wu D Local accession number: B2018644 Add to cart (remove)
	71.	Enhancing techniques for radioiodine imaging of differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Van Nostrand, Douglas Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Gomes-Lima CJ Turner D Van Nostrand D. Wu D Local accession number: B2018647 Add to cart (remove)
	72.	#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_159 Add to cart (remove)
	73.	The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit. MedStar authors: Elboga, Umut Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D Local accession number: 2013_160 Add to cart (remove)
	74.	Characterization of Sialoadenitis (SA) after administration of continuous Sialogogues (SGs) during the day and night after 131I therapy (tx). MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation Local accession number: 2013_230 Add to cart (remove)
	75.	Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_162 Add to cart (remove)
	76.	Glucose concentration modulates the efficacy of treatment with metformin in medullary thyroid cancer cells MedStar authors: Bikas, Athanasios Burman, Kenneth D Wartofsky, Leonard Year: 2016 Citation: Unpublished 2016/03/14 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bikas A, Jensen K, Patel A, Costello J, Wartofsky L, Burman K, Vasko V Local accession number: 2016_53 Add to cart (remove)
	77.	Brain metastases from differentiated thyroid carcinoma: current therapies and outcomes. MedStar authors: Burman, Kenneth D Deeb, Hala Gomes-Lima, Christiane J Hritani, Rama Mete, Mihriye Punukollu, Sree Rao, Sarika Van Nostrand, Douglas Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Deeb H Gomes-Lima C Hritani R Jonklaas J Mete M Punukollu S Rao S Van Nostrand D Wu D Zeymo A Local accession number: A2017_568 Add to cart (remove)
	78.	<sup>18</sup>F-FDG-PET SUV AS A PROGNOSTIC MARKER OF INCREASING SIZE IN THYROID CANCER TUMORS. MedStar authors: Bikas, Athanasios Burman, Kenneth D Desale, Sameer Garcia, Carlos Singh, Ishita Wartofsky, Leonard PMID: 27849386 Year: 2017 Citation: Endocrine Practice. 23(2):182-189, 2017 Feb Institution: MedStar Heart & Vascular Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bikas A, Burman KD, Desale S, Garcia CA, Singh I, Wartofsky L DOI: https://dx.doi.org/10.4158/EP161390.OR Add to cart (remove)
	79.	Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models. MedStar authors: Burman, Kenneth D Van Nostrand, Douglas Wartofsky, Leonard PMID: 28790138 Year: 2017 Citation: Endocrine Connections. , 2017 Aug 08 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman K, Costello J, Jensen K, Klubo-Gwiezdzinska J, Patel A, Tkavc R, Van Nostrand D, Vasko V, Wartofsky L DOI: https://dx.doi.org/10.1530/EC-17-0138 Add to cart (remove)
	80.	Conventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review] MedStar authors: Van Nostrand, Douglas Wartofsky, Leonard Ylli, Dorina PMID: 30717901 Year: 2019 Citation: Endocrinology & Metabolism Clinics of North America. 48(1):181-197, 2019 03. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Van Nostrand D, Wartofsky L, Ylli D DOI: https://dx.doi.org/10.1016/j.ecl.2018.11.005 Add to cart (remove)
	81.	Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer. MedStar authors: Burman, Kenneth D Gomes-Lima, Cristiane J Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 31451488 Year: 2020 Citation: Journal of Nuclear Medicine. 61(3):397-404, 2020 03. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bloom G, Burman KD, Gomes-Lima CJ, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.2967/jnumed.119.230730 Add to cart (remove)
	82.	The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging. MedStar authors: Burman, Kenneth D Garcia, Carlos Kulkarni, Kanchan Plyku, Donika Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 33323865 Year: 2021 Citation: Nuclear Medicine Communications. 42(3):292-299, 2021 Mar 01. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman KD, Garcia C, Kulkarni K, Plyku D, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.1097/MNM.0000000000001330 Add to cart (remove)
	83.	30 mCi exploratory scan for two-step dosimetric 131I therapy in differentiated thyroid cancer patients: A novel approach and case report. MedStar authors: Burman, Kenneth D Gomes-Lima, Cristiane J Kulkarni, Kanchan Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 33354183 Year: 2020 Citation: World Journal of Nuclear Medicine. 19(3):266-270, 2020 Jul-Sep. Institution: MedStar Health Research Institute Jeyce MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Case Reports Form of publication: Journal Article All authors: Burman KD, Gomes-Lima CJ, Kulkarni K, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.4103/wjnm.WJNM_35_19 Add to cart (remove)
	84.	Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer. MedStar authors: Atkins, Francis Burman, Kenneth D Garcia, Carlos Kulkarni, Kanchan Plyku, Donika Tefera, Eshetu Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 33492859 Year: 2021 Citation: Clinical Nuclear Medicine. 2021 Jan 21 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Burman KD, Garcia C, Kulkarni K, Plyku D, Tefera E, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.1097/RLU.0000000000003505 Add to cart (remove)
	85.	Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Garcia, Carlos A Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Garcia C Kulkarni K Van Nostrand D. Wartofsky L Wu D Local accession number: B2018645 Add to cart (remove)
	86.	Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors: Burman, Kenneth D Kulkarni, Kanchan P Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Kharazi P Khorjekar G Kulkarni K Moreau S Van Nostrand D. Wartofsky L Wu D Local accession number: B2018646 Add to cart (remove)
	87.	Overall survival rate of patients with differentiated thyroid cancer bone metastasis. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Kulkarni, Kanchan P Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Zeymo, Alexander Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Gomes Lima C Kulkarni K Moreau S Van Nostrand D Wartofsky L Wu D Zeymo A Local accession number: A2017_575 Add to cart (remove)
	88.	Thyroid stimulating hormone (TSH) suppression is not associated with better outcomes in intermediate and high risk thyroid cancer patients MedStar authors: Bikas, Athanasios Burman, Kenneth D Wartofsky, Leonard Year: 2016 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Klubo-Gwiezdzinska J, Wartofsky L, Burman K, Bikas A, et al Local accession number: 2016_240 Add to cart (remove)
	89.	Amifostine used clinically for salivary gland protection during therapy with radioiodine is cytotoxic for thyroid cancer cells MedStar authors: Burman, Kenneth D Klubo-Gwiezdzinska, Joanna Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unpublished 2014 May 6 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Klubo-Gwiezdzinska J, Costello Jr J, Jensen K, Patel A, Van Nostrand D,Burman KD, Wartofsky L, Vasko V Local accession number: 2014.1_2 Add to cart (remove)
	90.	New use for an old isotope. MedStar authors: Burman, Kenneth D Gomes Lima, Christiane J Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Ylli, Dorina Year: 2018 Citation: 2018/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Gomes Lima C Van Nostrand D. Wartofsky L Wu D Ylli D Local accession number: B201874 Add to cart (remove)
	91.	Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Garcia, Carlos A Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Kulkarni K Burman K Garcia C Van Nostrand D. Wartofsky L Wu D Local accession number: B201889 Add to cart (remove)
	92.	Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_161 Add to cart (remove)
	93.	The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors: Bethancourt, E Bikas, A Burman, Kenneth D Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l Local accession number: 2015_190 Add to cart (remove)
	94.	Assessment of the role of cytochrome C oxidase subunit 4 (COX4) in differentiated thyroid cancer MedStar authors: Bikas, Athanasios Burman, Kenneth D Wartofsky, Leonard Year: 2016 Citation: Unpublished 2016/03/14 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bikas A, Jensen K, Patel A, Costello J, Wartofsky L, Burman K, Vasko V Local accession number: 2016_55 Add to cart (remove)
	95.	Overall survival rate of patients with differentiated thyroid cancer bone metastasis. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Kulkarni, Kanchan P Moreau, Shari L Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman KD Gomes-Lima CJ Kulkarni K Moreau SL Van Nostrand D Wartofsky L Wu D Zeymo A Local accession number: A2017_074 Add to cart (remove)
	96.	Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. MedStar authors: Burman, Kenneth D Klubo-Gwiezdzinska, Joanna Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard PMID: 22313411 Citation: Thyroid. 22(3):310-7, 2012 Mar. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Comparative Study Journal Article Form of publication: Journal Article All authors: Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2011.0235 Add to cart (remove)
	97.	Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors: Atkins, Francis Burman, Kenneth Garcia, Carlos Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard PMID: 24820222 Citation: Thyroid. 24(9):1394-9, 2014 Sep. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2013.0713 Add to cart (remove)
	98.	Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer. MedStar authors: Bikas, Athanasios Burman, Kenneth D Desale, Sameer Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard PMID: 26649977 Year: 2016 Citation: Thyroid. 26(2):280-6, 2016 Feb Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bikas A, Burman KD, Desale S, Jensen K, Mete M, Patel A, Van Nostrand D, Vasko V, Wartofsky L DOI: https://dx.doi.org/10.1089/thy.2015.0413 Add to cart (remove)
	99.	Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors: Bethancourt, Evelyn Bikas, Athanasios Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 30361377 Year: 2019 Citation: Journal of Nuclear Medicine. 60(5):638-643, 2019 05. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.2967/jnumed.118.213256 Add to cart (remove)
	100.	Radioiodine treatment of metastatic thyroid cancer: progression free survival is similar for patients with distant metastases prepared with recombinant human tsh or with thyroid hormone withdrawal. MedStar authors: Al-Jundi, Mohammad Burman, Kenneth D Chittimoju, Sanjita Gomes Lima, Christiane J Jat, Sunita Jhawar, Sakshi Pagadala, Prathyusha Van Nostrand, Douglas Wartofsky, Leonard Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Al-Jundi MN Burman KD Chittimoju S ENDO 2018, Gomes-Lima CJ Jat SK Jhawar S Jonklaas J Klubo-Gwiezdzinska J Mete M Pagadala P Van Nostrand D Wartofsky L Wehbeh L Zeymo A Local accession number: B2018452 Add to cart (remove)

Refine your search

Authors

Item types

Topics

Collections

Languages

Your search returned 160 results.